4.7 Article

Efficacy evaluation of intravenous immunoglobulin in non-severe patients with COVID-19: A retrospective cohort study based on propensity score matching

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

A new coronavirus associated with human respiratory disease in China

Fan Wu et al.

NATURE (2020)

Letter Medicine, General & Internal

Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany

Camilla Rothe et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Editorial Material Biochemistry & Molecular Biology

Could Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients?

Samir Jawhara

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Oncology

Effectiveness of intravenous immunoglobulin for children with severe COVID-19: a rapid review

Jingyi Zhang et al.

ANNALS OF TRANSLATIONAL MEDICINE (2020)

Review Immunology

Immunoglobulins in the treatment of COVID-19 infection: Proceed with caution!

Alan A. Nguyen et al.

CLINICAL IMMUNOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Statistical primer: propensity score matching and its alternatives

Umberto Benedetto et al.

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2018)

Review Immunology

IVIG-mediated effector functions in autoimmune and inflammatory diseases

Caroline Galeotti et al.

INTERNATIONAL IMMUNOLOGY (2017)

Editorial Material Medicine, General & Internal

The Propensity Score

Jason S. Haukoos et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)

Review Medicine, General & Internal

SARS: Systematic review of treatment effects

Lauren J. Stockman et al.

PLOS MEDICINE (2006)

Article Immunology

Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients

JT Wang et al.

EMERGING INFECTIOUS DISEASES (2004)